Review of four major biomolecular target sites for COVID-19 and possible inhibitors as treatment interventions

5/8 Review

Vigbedor et al., Journal of Applied Pharmaceutical Science, doi:10.7324/JAPS.2021.110825 (Review) (Peer Reviewed)
Review of four major biomolecular target sites for COVID-19 and possible inhibitors as treatment interventions

Source PDF Share Tweet

Review of major target sites in SARS-CoV-2 and the host organism along with potential inhibitors.

Vigbedor et al., 5/8/2021, peer-reviewed, 8 authors.

All 344 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit